UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000011116
Receipt No. R000013025
Scientific Title Effect of left uterine displacement and leg elevation on decrease in maternal cerebral blood flow and oxygenation during spinal anesthesia for cesarean section; prospective randomized control trial
Date of disclosure of the study information 2013/07/08
Last modified on 2019/07/09 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of left uterine displacement and leg elevation on decrease in maternal cerebral blood flow and oxygenation during spinal anesthesia for cesarean section; prospective randomized control trial
Acronym Effect of left uterine displacement and leg elevation on decrease in maternal cerebral blood flow and oxygenation during spinal anesthesia for cesarean section
Scientific Title Effect of left uterine displacement and leg elevation on decrease in maternal cerebral blood flow and oxygenation during spinal anesthesia for cesarean section; prospective randomized control trial
Scientific Title:Acronym Effect of left uterine displacement and leg elevation on decrease in maternal cerebral blood flow and oxygenation during spinal anesthesia for cesarean section
Region
Japan

Condition
Condition Full term pregnancy
Classification by specialty
Obsterics and gynecology Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Suppressive effect of left uterine displacement and leg elevation on decrease in maternal cerebral blood flow and oxygenation during spinal anesthesia for cesarean section
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change in maternal cerebral blood flow and oxygenation after spinal anesthesia for cesarean section evaluated by near infrared spectroscopy (NIRS)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 4
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Keep the horizontal supine position during 20 min after intrathecal infusion of bupivacaine
Interventions/Control_2 Left uterine displacement by surgical bed rotation during 20 min after intrathecal infusion of bupivacaine
Interventions/Control_3 Leg elevation at an angle of 30 degrees to the horizontal during 20 min after intrathecal infusion of bupivacaine
Interventions/Control_4 Combination of left uterine displacement and leg elevation during 20 min after intrathecal infusion of bupivacaine
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Healthy full-term pregnant woman aged over 18, undergoing elective cesarean section under spinal anesthesia
Key exclusion criteria Patient with a diagnosis of hypertension, diabetes and renal dysfunction due to pregnancy, and obese patient whose BMI >30
Target sample size 80

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yuko Kondo
Organization Nihon University School of Medicine
Division name Division of Anesthesiology, Department of Anesthesiology
Zip code
Address 30-1, Oyaguchi-Kamicho, Itabashi-ku, Tokyo, Japan
TEL 03-3972-8111
Email

Public contact
Name of contact person
1st name
Middle name
Last name
Organization Nihon University School of Medicin
Division name Division of Anesthesiology, Department of Anesthesiology
Zip code
Address 30-1, Oyaguchi-Kamicho, Itabashi-ku, Tokyo, Japan
TEL
Homepage URL
Email

Sponsor
Institute Nihon University School of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 日本大学医学部附属板橋病院(東京都)

Other administrative information
Date of disclosure of the study information
2013 Year 07 Month 08 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 06 Month 15 Day
Date of IRB
2013 Year 08 Month 09 Day
Anticipated trial start date
2013 Year 07 Month 08 Day
Last follow-up date
2014 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2013 Year 07 Month 04 Day
Last modified on
2019 Year 07 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013025